[1] |
Alvarez-Alvarez I, Niu H, Guillen-Grima F, et al. Meta-analysis of prevalence of wheezing and recurrent wheezing in infants[J]. Allergol Immunopathol (Madr), 2018, 46(3): 210-217.
|
[2] |
魏琳,张玉娥,金惠娣,等. 反复喘息患儿1 035例随访分析[J]. 临床儿科杂志,2014, 32(6): 532-535.
|
[3] |
钱胜华,张莉,王晓花,等. 5岁以下儿童反复喘息发作呼吸道病原分析[J]. 临床肺科杂志,2016, 21(12): 2249-2251.
|
[4] |
Rossi GA, Colin AA. Infantile respiratory syncytial virus and human rhinovirus infections: respective role in inception and persistence of wheezing[J]. Eur Respir J, 2015, 45(3): 774-789.
|
[5] |
Takeyama A, Hashimoto K, Sato M, et al. Clinical and epidemiologic factors related to subsequent wheezing after virus-induced lower respiratory tract infections in hospitalized pediatric patients younger than 3 years[J]. Eur J Pediatr, 2014, 173(7): 959-966.
|
[6] |
Ding FX, Luo J, Fu Z. Research progress in the relationship between childhood wheezing and bacteria[J]. Chin J Contemp Pediatr, 2015, 17(5): 528-532.
|
[7] |
赵志云. 儿童哮喘与肺炎支原体感染检验结果及相关性探讨[J]. 临床肺科杂志,2014, 19(8): 1497-1498.
|
[8] |
Abrahamsson TR, Sandberg Abelius M, Forsberg A, et al. A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization[J]. Clin Exp Allergy, 2011, 41(12): 1729-1739.
|
[9] |
江霞辉,陆俏群,赵若雯. 毛细支气管炎与哮喘患儿T淋巴细胞亚群及干扰素-γ、白介素-4的对比分析[J]. 中国妇幼保健,2013, 28(23): 3784-3786.
|
[10] |
毛国其,蒋文良. 小儿呼吸道合胞病毒毛细支气管炎血Th17/Treg失衡机制及意义[J]. 中国妇幼健康研究,2017, 28(12): 1734-1735.
|
[11] |
Chkhaidze I, Zirakishvili D, Shavshvishvili N, et al. Prognostic value of TH1/TH2 cytokines in infants with wheezing in a three year follow-up study[J]. Pneumonol Alergol Pol, 2016, 84(3): 144-150.
|
[12] |
Guilbert TW, Morgan WJ, Krawiec M, et al. The prevention of early asthma in kids study: design, rationale and methods for the childhood asthma research and education network[J]. Control Clin Trials, 2004, 25(3): 286-310.
|
[13] |
赵德育. 婴幼儿喘息流行病学及发展趋势[J]. 中国实用儿科杂志,2014, 29(6): 401-404.
|
[14] |
Amin P, Levin L, Epstein T, et al. Optimum predictors of childhood asthma: persistent wheeze or the asthma predictive index?[J]. J Allergy Clin Immunol Pract, 2014, 2(6): 709-715.
|
[15] |
Burbank AJ, Szefler SJ. Current and future management of the young child with early onset wheezing[J]. Curr Opin Allergy Clin Immunol, 2017, 17(2): 146-152.
|
[16] |
Price D, Ryan D, Burden A, et al. Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care[J]. Clin Transl Allergy, 2013, 3(1): 37.
|
[17] |
蔡青,邓金强. 婴幼儿喘息性疾病FeNO检测与sIgE、IgE的相关性分析[J]. 中国医药导报,2017, 14(12): 97-100.
|
[18] |
王红,兰常肇,马少杰,等. 婴幼儿反复喘息与血清维生素D水平相关性研究[J]. 国际儿科学杂志,2014,7(4): 421-423.
|
[19] |
孙秋凤,蒋吴君,陈正荣,等. 血清25-羟维生素D3水平与婴儿喘息关系及临床意义探讨[J]. 中国实用儿科杂志,2015, 30(3): 199-202.
|
[20] |
徐艳娜,顾建华,李永莲,等. 反复喘息婴幼儿维生素D3水平及与Th1/Th2细胞平衡变化的相关性研究[J]. 中华实用儿科临床杂志,2015, 30(4): 264-266.
|
[21] |
Nenna R, Ferrara M, Nicolai A, et al. Viral load in infants hospitalized for respiratory syncytial virus bronchiolitis correlates with recurrent wheezing at thirty-six-month follow-up[J]. Pediatr Infect Dis J, 2015, 34(10): 1131-1132.
|
[22] |
de Sousa RB, Medeiros D, Sarinho E, et al. Risk factors for recurrent wheezing in infants: a case-control study[J]. Rev Saude Publica, 2016, 50: 15.
|
[23] |
田曼,赵德育,文惯宇,等. RSV毛细支气管炎及其后反复相关影响因素分析[J]. 中华实验和临床病毒学杂志,2009, 23(5): 371-374.
|
[24] |
Aranda CS, Wandalsen G, Fonzar L, et al. Risk factors for recurrent wheezing--International Study of Wheezing in Infants (EISL) phase 3[J]. Allergol Immunopathol (Madr), 2016, 44(1): 3-8.
|
[25] |
曹向可,王维,钱庆增,等. 3岁以下婴幼儿喘息的危险因素分析[J]. 广东医学,2017, 38 (10): 1548-1551.
|
[26] |
Miller EK, Avila PC, Khan YW, et al. Wheezing exacerbations in early childhood: evaluation, treatment, and recent advances relevant to the genesis of asthma[J]. J Allergy Clin Immunol Pract, 2014, 2(5): 537-543.
|
[27] |
单文婕,卢燕鸣,李亚琴,等. 婴幼儿反复喘息危险因素Meta分析[J]. 中华实用儿科临床杂志,2015, 30(10): 761-764.
|
[28] |
Zeiger RS, Mauger D, Bacharier LB, et al. Daily or intermittent budesonide in preschool children with recurrent wheezing[J]. N Engl J Med, 2011, 365(21): 1990-2001.
|
[29] |
Tenero L, Piazza M, Piacentini G, et al. Recurrent wheezing in children[J]. Transl Pediatr, 2016, 5(1): 31-36.
|
[30] |
Beigelman A, Bacharier LB. Management of preschool recurrent wheezing and asthma: a phenotype-based approach[J]. Curr Opin Allergy Clin Immunol, 2017, 17(2): 131-138.
|
[31] |
Sears MR. Predicting asthma outcomes[J]. J Allergy Clin Immunol, 2015, 136(4): 829-836.
|
[32] |
储昭乐,彭美芳,李章. 吸入糖皮质激素预防毛细支气管炎后喘息随机对照试验的Meta分析[J/CD]. 中华临床医师杂志(电子版), 2013, 7(19): 8813-8820.
|
[33] |
徐红艳,周罗根. 婴幼儿毛细支气管炎后喘息的干预[J]. 实用临床医药杂志,2014, 18(24): 150-160.
|
[34] |
Peng WS, Chen X, Yang XY, et al. Systematic review of montelukast′s efficacy for reventing post-bronchiolitis wheezing[J]. Pediatr Allergy Immunol, 2014, 25(2): 143-150.
|
[35] |
Stokholm J, Chawes BL, Vissing NH, et al. Azithromycin for episodes with asthma-like symptoms in young children aged 1-3 years: a randomised, double-blind, placebo-controlled trial[J]. Lancet Respir Med, 2016, 4(1): 19-26.
|
[36] |
Beigelman A, Isaacson-Schmid M, Sajol G, et al. Randomized trial to evaluate azithromycin′s effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis[J]. J Allergy Clin Immunol, 2015, 135(5): 1171-1178.
|
[37] |
田野,嵇若旭,鲍一笑,等. 阿奇霉素在婴幼儿喘息联合降阶梯疗法中的疗效[J]. 中华实用儿科杂志,2014, 29(4): 261-264.
|
[38] |
Mochizuki H, Kusuda S, Okada K, et al. Palivizumab prophylaxis in preterm infants and subsequent recurrent wheezing: 6 year follow up study[J]. Am J Respir Crit Care Med, 2017, 196(1): 29-38.
|
[39] |
Lemanske RF Jr. Early life wheezing and respiratory syncytial virus prevention[J]. N Engl J Med, 2013, 368(19): 1839-1841.
|
[40] |
黄花荣,曾森强,吴敬芳. 大剂量丙种球蛋白对喘息婴儿外周血IL-4和CD20水平以及喘息再发的影响[J]. 中国病理生理杂志,2010, 26(8): 1575-1578.
|
[41] |
李缙. 静脉滴注丙种球蛋白治疗毛细支气管炎的临床疗效观察[J]. 儿科药学杂志,2017, 28(8): 32-35.
|